导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 43.10% | 88/1050 |
| 近一周 | 2.95% | 53/1104 |
| 近一月 | -0.75% | 201/1103 |
| 近一季 | -9.28% | 668/1092 |
| 近半年 | 31.75% | 78/1070 |
| 近一年 | 40.71% | 115/1018 |
| 近两年 | 131.66% | 136/926 |
| 近三年 | 71.86% | 159/834 |
| 成立以来 | 114.30% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-0.50% 524/1070 |
90.84% 70/1101 |
- - |
- - |
| 2025 | 18.18% 695/1065 |
2.80% 564/1014 |
-3.80% 923/1038 |
32.91% 322/1050 |
-10.10% 884/1065 |
| 2024 | 1.07% 549/1011 |
-12.27% 830/960 |
-4.18% 583/983 |
10.22% 607/991 |
9.08% 67/1011 |
| 2023 | 3.31% 57/952 |
32.99% 6/880 |
-5.19% 537/895 |
-17.77% 829/915 |
-0.35% 137/952 |
| 2022 | -25.80% 523/867 |
-26.53% 727/773 |
4.80% 527/806 |
-8.02% 143/845 |
4.76% 217/867 |
| 2021 | 13.90% 198/740 |
-5.66% 369/580 |
18.61% 178/659 |
-7.41% 435/704 |
9.93% 87/740 |
| 2020 | 44.61% 269/554 |
6.56% 60/419 |
20.24% 281/466 |
0.54% 412/517 |
12.25% 283/554 |
| 2019 | 80.01% 9/410 |
30.52% 351/1149 |
-6.85% 844/1231 |
23.49% 10/390 |
19.89% 14/410 |
| 2018 | -26.64% 171/349 |
- - |
- - |
- - |
-12.99% 730/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 创金合信科技成长股票A VS. 东吴新产业精选股票A(580008) |